Skip to the page
pepts.wiki

We are not doctors and nothing here is medical advice. Always consult a medical professional first. Why we say this

Studied in peopleStub

CJC-1295 with DAC

Long-acting GHRH analogue

A GHRH analogue with a drug affinity complex that binds albumin and extends its half-life to days. Early trials in healthy adults measured growth hormone and IGF-1.

Reconstitution calculator

At a glance

Studied in people

There are published studies in people. It is not a licensed medicine in the United States or the European Union.

This page is a stub

The wiki has this compound's identity from the My-Pepts library, its standing, and what PubMed holds for it. The article, with its studies read and cited, is not written yet. Until it is, the counts below say how much research exists, not what it found.

How strong is the evidence

How far it has climbed

Every medicine climbs the same ladder. Most compounds never reach the top, and where one stands says how much its claims can carry.

  1. Licensed medicine

    A regulator has reviewed the trials and licensed it for a named use.

  2. Phase 3

    Large randomized trials, often thousands of people, against placebo or a standard treatment.

  3. Phase 2

    Mid-sized trials that measure dose against effect in people with the condition.

  4. Phase 1 and early human studies: CJC-1295 with DAC

    First studies in people: safety, and how the body handles it.

  5. Cells and animals

    Laboratory and animal work. An animal result is not a result in people.

35
papers on PubMed
22
of them in people
1
randomized trials
11
reviews

A count says how much has been published, not what it found. Counted on PubMed: 2026-11-16

Handling and reconstitution

From powder to a measured sample

The same four steps for any lyophilized vial. Laboratory handling, not use in a person.

  1. 1. Read the vial

    The label gives the mass of peptide in the vial, in milligrams. That number is the start of every calculation.

  2. 2. Add the diluent

    A measured volume of diluent goes in slowly, down the glass. Swirl gently; shaking can damage a peptide.

  3. 3. Work out the strength

    Concentration is mass divided by volume: 10 mg in 2 mL is 5 mg per mL.

  4. 4. Measure the sample

    Volume is the mass wanted divided by the concentration. On a U-100 syringe, 1 mL is 100 units.

The calculator below does the arithmetic and shows its working.

As powder

General practice for lyophilized peptides: keep the sealed vial frozen or refrigerated, dry and away from light, and follow the supplier's certificate of analysis.

In solution

Once in solution a peptide is kept refrigerated and used within the period the supplier states. A vial drawn from more than once needs a preserved diluent such as bacteriostatic water.

This is general practice for lyophilized peptides, not data on CJC-1295 with DAC itself. The batch's certificate of analysis and the supplier's sheet are the facts to go by. More on storage

Reconstitution calculator

Opens on vial sizes common for research peptides. Change any number. How the arithmetic works

Draw to

10 units

0.1 mL on a U-100 syringe

Concentration
2.5 mg/mL
Each unit holds
25 mcg
Samples in the vial
20
Sample
250 mcg

5 mg in 2 mL is 2.5 mg/mL. 250 mcg of that is 0.1 mL, which reads as 10 units. This is arithmetic for a vial of CJC-1295 with DAC; no amount here is a recommendation.

CJC-1295 with DAC: on PubMed

What PubMed held for CJC-1295 with DAC on November 16, 2026. A count says how much a compound has been studied, not what the studies found: how to read these numbers.

35
papers
22
in humans
2
clinical trials
1
randomized trials
2012: 1 papers122013: 1 papers2014: 1 papers142015: 1 papers2016: 3 papers162017: 0 papers2018: 1 papers182019: 2 papers2020: 1 papers202021: 2 papers2022: 3 papers222023: 1 papers2024: 1 papers242025: 1 papers2026: 12 papers so far26
Papers per year, 2012 to 2026. The most in one year: 12.

Most relevant on PubMed

Listed by PubMed's own relevance ranking, trials and reviews first. The wiki has not read these into the article unless they are also among its sources.

  1. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults

    Randomized trialTeichman SL, Neale A, Lawrence B, et al. The Journal of clinical endocrinology and metabolism, 2006. PMID 16352683

  2. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog

    TrialIonescu M, Frohman LA The Journal of clinical endocrinology and metabolism, 2006. PMID 17018654

  3. Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians

    ReviewMayfield CK, Bolia IK, Feingold CL, et al. The American journal of sports medicine, 2026. PMID 41476424

  4. Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions

    ReviewRahman OF, Lee SJ, Seeds WA Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews, 2026. PMID 41490200

  5. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance

    ReviewMendias CL, Awan TM Sports medicine (Auckland, N.Z.), 2026. PMID 41966639

  6. Advances in the detection of growth hormone releasing hormone synthetic analogs

    StudyMemdouh S, Gavrilović I, Ng K, et al. Drug testing and analysis, 2021. PMID 34665524

  7. Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects

    StudySackmann-Sala L, Ding J, Frohman LA, et al. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 2009. PMID 19386527

Search used: ("CJC-1295"[tiab] OR "CJC 1295"[tiab]). Run it on PubMed

Research links

Also in GH axis